Comparison of the Elecsys® Anti-SARS-CoV-2 immunoassay with the EDITM enzyme linked immunosorbent assays for the detection of SARS-CoV-2 antibodies in human plasma
Both of Epitope Diagnostics’ Anti-SARS-COV-2 antibody assays (IgG and IgM) have been featured in a head-to-head comparison against Elecsys® Anti-SARS-CoV-2. Elecsys® Anti-SARS-CoV-2 is manufactured by Roche Diagnostics and has been the gold-standard in the diagnostics industry for automated assays.
Abstract: Recently, Roche Diagnostics (Rotkreuz, Switzerland) has launched the IVD CE-marked Elecsys® Anti-SARS-CoV-2 assay for the qualitative detection of SARS-CoV-2 antibodies on the cobas e immunoassay analyzers. The aim of this study was to compare the clinical performance of the Elecsys® Anti-SARS-CoV 2 assay with the EDITM SARS-CoV-2 IgM and IgG enzyme linked immunosorbent assays (ELISA), which we have recently established in our laboratory.